Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
For full access to this article login to GEN Select now.
Microarrays & Sequencing Assume Supporting Roles
Which Tool Is Best Depends on the Question Asked and the System Being Surveyed
- Recent decades have marked exciting times for biological sciences. Since the 1977 milestone publication of the first genome, that of the single-stranded bacteriophage ΦX174, new methodologies that culminated with the implementation of next- and next-next generation sequencing platforms and the advent of -omics sciences facilitated a level of scrutiny ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.